{
    "moduleId": "module_33",
    "moduleTitle": "L4: Legal & Compliance",
    "passingScore": 80,
    "questions": [
        {
            "id": "q33_1",
            "question": "A practitioner licensed as a Health Coach provides a client with a specific protocol to 'cure' their diagnosed Type 2 Diabetes using high-dose chromium and berberine. Which legal boundary has been most clearly violated?",
            "options": [
                "The Corporate Practice of Medicine doctrine",
                "Practicing medicine without a license by diagnosing and prescribing",
                "Violation of the DSHEA 1994 labeling requirements",
                "Breach of the 'Minimum Necessary' standard under HIPAA"
            ],
            "correctAnswer": 1,
            "explanation": "Defining professional scope (L1) dictates that non-licensed practitioners cannot 'treat' or 'cure' diagnosed diseases. Recommending a protocol to 'cure' a clinical diagnosis constitutes the practice of medicine without a license."
        },
        {
            "id": "q33_2",
            "question": "In 'Advanced Informed Consent' for integrative therapies, what is the 'Materiality Standard' used by many courts to determine if a practitioner disclosed enough information?",
            "options": [
                "What a 'reasonable practitioner' would disclose in the same situation",
                "What the specific practitioner thinks is important for the client to know",
                "What a 'reasonable patient' would want to know to make an informed decision",
                "Only the risks that have a greater than 5% occurrence rate in clinical trials"
            ],
            "correctAnswer": 2,
            "explanation": "The 'reasonable patient' (or objective) standard focuses on what a prudent person in the patient's position would need to know to make an intelligent decision regarding the proposed treatment (L2)."
        },
        {
            "id": "q33_3",
            "question": "Under the principle of 'Vicarious Liability' (Respondeat Superior), which of the following is true for an integrative clinic owner?",
            "options": [
                "The owner is only liable for their own personal clinical errors",
                "The owner can be held legally responsible for the negligent acts of employees committed within the scope of employment",
                "Liability is waived if the employee signed an independent contractor agreement",
                "The owner is only liable if they were physically present during the incident"
            ],
            "correctAnswer": 1,
            "explanation": "Vicarious liability (L3) holds employers/owners responsible for the actions of their staff performed during the course of their professional duties, regardless of the owner's direct involvement."
        },
        {
            "id": "q33_4",
            "question": "A practitioner uses a cloud-based Electronic Health Record (EHR) system. To be HIPAA compliant, what document MUST be signed between the practitioner and the EHR provider?",
            "options": [
                "A Non-Disclosure Agreement (NDA)",
                "A Professional Services Contract",
                "A Business Associate Agreement (BAA)",
                "An Informed Consent for Data Transmission"
            ],
            "correctAnswer": 2,
            "explanation": "HIPAA requires a Business Associate Agreement (BAA) with any third-party vendor that handles, stores, or transmits Protected Health Information (PHI) on behalf of a covered entity (L4)."
        },
        {
            "id": "q33_5",
            "question": "Which of the following marketing claims for a Vitamin D supplement would most likely trigger an FTC or FDA enforcement action?",
            "options": [
                "Supports healthy immune system function",
                "Promotes strong bones and calcium absorption",
                "Reduces the inflammation associated with Rheumatoid Arthritis",
                "Maintains optimal serum Vitamin D levels"
            ],
            "correctAnswer": 2,
            "explanation": "Under DSHEA (L5), supplements may only make 'structure/function' claims. Claiming to reduce inflammation associated with a specific disease (Rheumatoid Arthritis) is considered an unauthorized 'disease claim' and is prohibited."
        },
        {
            "id": "q33_6",
            "question": "A practitioner refers patients to a specific compounding pharmacy and receives a 'marketing fee' for every prescription filled. This arrangement likely violates which federal law?",
            "options": [
                "The Anti-Kickback Statute (AKS)",
                "The HIPAA Security Rule",
                "The Fair Labor Standards Act (FLSA)",
                "The Dietary Supplement Health and Education Act (DSHEA)"
            ],
            "correctAnswer": 0,
            "explanation": "The Anti-Kickback Statute (L6) prohibits the exchange of anything of value (remuneration) in return for referrals for services or items covered by federal healthcare programs."
        },
        {
            "id": "q33_7",
            "question": "The 'Corporate Practice of Medicine' (CPOM) doctrine, active in many U.S. states, primarily seeks to prevent:",
            "options": [
                "Doctors from forming Limited Liability Companies (LLCs)",
                "Non-physicians or corporations from interfering with a physician's independent medical judgment",
                "The sale of supplements within a clinical environment",
                "Practitioners from using telehealth across state lines"
            ],
            "correctAnswer": 1,
            "explanation": "CPOM (L7) is a legal doctrine that prohibits corporations or non-licensed individuals from practicing medicine or employing physicians to provide medical services, ensuring clinical decisions are not driven by corporate profit."
        },
        {
            "id": "q33_8",
            "question": "When using a patient testimonial in marketing, the FTC 'Guides Concerning the Use of Endorsements and Testimonials' require that:",
            "options": [
                "The patient must remain anonymous for HIPAA compliance",
                "The practitioner must disclose any 'material connection' (e.g., free product or payment) given to the endorser",
                "Testimonials can only be used if the results are 100% guaranteed for all future clients",
                "Testimonials are exempt from truth-in-advertising laws if they are 'opinion-based'"
            ],
            "correctAnswer": 1,
            "explanation": "The FTC (L5/L8) requires clear and conspicuous disclosure of any material connection between an endorser and the marketer that might affect the weight or credibility of the endorsement."
        },
        {
            "id": "q33_9",
            "question": "Which ethical concept describes a situation where a practitioner enters into a secondary relationship with a client (e.g., a business partnership or social friendship) that risks impairing professional judgment?",
            "options": [
                "Informed Consent Gap",
                "Standard of Care Deviation",
                "Dual Relationship / Boundary Crossing",
                "Jurisdictional Arbitrage"
            ],
            "correctAnswer": 2,
            "explanation": "Dual relationships (L8) occur when a practitioner has more than one role with a client, which can create conflicts of interest and compromise the therapeutic relationship and professional objectivity."
        },
        {
            "id": "q33_10",
            "question": "In the 'Three-Talk Model' of Shared Decision-Making (SDM), what is the primary goal of 'Option Talk'?",
            "options": [
                "To tell the patient which option the practitioner prefers",
                "To provide detailed information about the alternatives, including risks and benefits",
                "To finalize the billing and payment options for the chosen treatment",
                "To screen the patient for eligibility for a clinical trial"
            ],
            "correctAnswer": 1,
            "explanation": "In the SDM framework (L2), 'Option Talk' involves providing the patient with clear, comparative information about the available treatment pathways, including the 'no treatment' option."
        }
    ]
}